CompletedPhase 3

Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)

1,640 participantsStarted 2006-05

Plain-language summary

This is a multicenter study to evaluate the efficacy and safety of MK0476 versus placebo in participants with chronic asthma who actively smoke cigarettes.

Who can participate

Age range18 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participants with chronic asthma who actively smoke at least 0.5 to no more than 2 packs of cigarettes a day Exclusion Criteria: * Participant cannot have a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) or emphysema.

What they're measuring

Percentage of Asthma-control Days Over the 6-month Treatment Period

Timeframe: 6 months

Trial details

NCT IDNCT00284856

SponsorOrganon and Co

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2010-04

Results submitted2011-04-06

View on ClinicalTrials.gov More Asthma trials